IRVING, Texas, Aug. 5, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, recently published a ...
This new article publication from Acta Pharmaceutica Sinica B, discusses an AI-integrated quality prediction and diagnostics framework that could transform small-sample pharmaceutical manufacturing ...